Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm ...

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...

Haleon PLC closed 5.73% below its 52-week high of £4.01, which the company reached on September 18th.

Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon , lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner JPMorgan said on ...

In a report released today, David Hayes from Jefferies maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...

Marcum Wealth LLC raised its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 19.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 24,714 shares of the company’s stock ...

ADR (HLN) stock saw a decline, ending the day at $9.53 which represents a decrease of $-0.01 or -0.10% from the prior close of $9.54. The stock opened at $9.45 and touched a low of $9.42 during the ...

AdvisorNet Financial Inc reduced its stake in shares of Haleon plc (NYSE:HLN – Free Report) by 34.0% in the fourth quarter, ...

Wednesday announced the sale of 700 million shares in Haleon Plc (HLN), a British multinational consumer healthcare ...